← All trials
NCT06518577
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 9, 2024
- Primary completion
- May 30, 2025
- Completion date
- May 30, 2025
- First posted
- Jul 24, 2024
- Last posted
- Oct 10, 2024
- Enrollment
- 600
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Duke UniversityLead sponsor
- Arizona State UniversityCollaborator
- Duke UniversityOfficial
- Centers for Disease Control and Prevention (CDC)Collaborator
- Washington University in St. LouisCollaborator
- Case Western Reserve UniversityCollaborator
- University of PittsburghCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.